KL
KIMBERLY LINTHICUM
TODD STRATEGY GROUP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
55
last 3 years
Filings
160
6 agencies contacted
Activity
filings by quarter
Works on
Health Issues 100Medicare/Medicaid 68Pharmacy 16Copyright/Patent/Trademark 9Budget/Appropriations 6Taxation/Internal Revenue Code 5Tobacco 4Banking 4Insurance 3Economics/Economic Development 3Financial Institutions/Investments/Securities 2Communications/Broadcasting/Radio/TV 2Telecommunications 2Advertising 2
Background
Government experience
Legislative Director
Representative Bob Franks; Legislative Correspondent, Representative Charles Taylor; Legislative Correspondent, Representative Bill Martini
Disclosed on LD-2 filings
Career
TS
Specific issues
Discussions concerning the FY 2024 appropriations bills; provisions related to FDA regulation of tobacco.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to tobacco harm reduction. Discussions related to enforcement of illicit tobacco products, including importation of counterfeit products. Discussions related to user fees for tobacco and electronic nicotine delivery system products. Discussions related to efforts to prevent youth access to tobacco products.
Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers.
Part D changes. Prescription drug payment reform. 340B issues. Onshoring. HELP Copays Act. General Medicare and Medicaid Issues.
340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues.
Drug Pricing. H.R. 830 HELP Copays Act.
Clients
Filing history
MERCK & CO., INC.
ADULT VACCINE ACCESS COALITION
ASTELLAS PHARMA US, INC.
AMERICAN POLICY VENTURES ACTION
PMI US CORPORATE SERVICES INC.
EMD SERONO INC.
ILLUMINA, INC.
ALEXION PHARMACEUTICALS, INC.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
MCKESSON CORPORATION
GENENTECH, INC.
BAYER CORPORATION